GameStop: Consensus Estimates Point To Negative EBITDA For Q3

GameStop (NYSE: GME) will be reporting its third quarter financial results on December 8th after the market closes. Analysts have a consensus $88 12-month price target on the company, via a total of 3 analysts, with 1 analyst having a hold rating, another analyst having a sell rating, and the last analyst having a strong sell rating. The street high comes in at a $190 price target, and the lowest target sits at $24.

Only 4 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 4 analysts is $1.19 billion; this number has been up and down but is flat now since early June. The highest revenue estimate is $1.30 billion, while the lowest is $1.01 billion.

Onto EBITDA estimates, there are currently only 2 analysts who have third quarter EBITDA estimates. The mean is currently -$15 million, with this number being slightly revised lower since early June. The street high estimate currently sits at $12 million in EBITDA and the lowest is -$42 million.

Analysts estimate that quarterly earnings per share will come in at -$0.52, with this number being flat since early June. Street high is -$0.04 and the lowest estimate is -$0.87 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Why Silver Still Hasn’t Seen the Real Mania | Craig Hemke

Why Copper Needs a Much Higher Price to Fix the Supply Problem | Greg Ferron – PTX Metals

Recommended

Goliath Resources Kicks Off Fully Funded 50,000 Metre Drill Program At Surebet

First Phosphate Lifts Bégin-Lamarche Indicated Tonnage by 378% In Latest Resource Update

Related News

Canaccord: CloudMD’s Third Quarter Results Were “In The Range Of Expectations”

On November 30th, CloudMD Software & Services (TSXV: DOC) reported its third-quarter financial results. CloudMD...

Tuesday, December 1, 2020, 03:41:00 PM

MicroStrategy: Canaccord Lowers Price Target To $780

MicroStrategy (NASDAQ: MSTR) reported its second quarter financial results on July 29. The company reported...

Tuesday, August 3, 2021, 11:35:00 AM

Cineplex Downgraded By Canaccord To Sell On Rising Debt Risks

On Friday, Cannacord Genuity downgraded Cineplex (TSX: CGX) from a Hold to a Sell rating...

Sunday, October 4, 2020, 11:48:00 AM

Canaccord Raises Coinbase Price Target Following Strong Earnings Growth

On August 10, Coinbase Global (NASDAQ: COIN) reported its second-quarter financial statements. For non-GAAP items,...

Saturday, August 14, 2021, 04:04:00 PM

PharmaTher: Maxim Initiates Coverage With US$1.50 Price Target

PharmaTher Holdings (CSE: PHRM) had its first initiation report that came out on June 28th....

Wednesday, June 30, 2021, 02:38:00 PM